Log in to save to my catalogue

Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-ca...

Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2918614486

Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-cancer efficacy

About this item

Full title

Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-cancer efficacy

Publisher

Heidelberg: Science China Press

Journal title

Science China. Chemistry, 2014-04, Vol.57 (4), p.624-632

Language

English

Formats

Publication information

Publisher

Heidelberg: Science China Press

More information

Scope and Contents

Contents

A series of well-defined amphiphilic linear-dendritic block copolymers (telodendrimers, MPEG-b-PAMAM-cholesterol) with 1,2,4 or 8 cholesteryl groups (named as P1, P2, P4, P8, respectively) were synthesized. Their chemical structures were char- acterized with IH NMR and mass spectrum (MALDI-TOF MS). The telodendrimers could self-assemble into micell...

Alternative Titles

Full title

Co-delivery of doxorubicin and paclitaxel with linear-dendritic block copolymer for enhanced anti-cancer efficacy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2918614486

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2918614486

Other Identifiers

ISSN

1674-7291

E-ISSN

1869-1870

DOI

10.1007/s11426-014-5078-y

How to access this item